Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385514235> ?p ?o ?g. }
- W4385514235 endingPage "3525" @default.
- W4385514235 startingPage "3514" @default.
- W4385514235 abstract "Abstract Purpose: Determinants of treatment outcomes to chemotherapy-based regimens in metastatic pancreatic ductal adenocarcinoma (PDA) remain ill-defined. Our aim was to examine tissue-based correlates of treatment response and resistance using matched baseline and on-treatment biopsies collected from patients with PDA treated in the first-line metastatic setting. Experimental Design: Patients with treatment-naïve metastatic PDA were enrolled in a Phase II trial (NCT02077881) investigating gemcitabine plus nab-paclitaxel in combination with indoximod, an orally administered small-molecule inhibitor of the IDO pathway. Baseline and on-treatment biopsies (week 8) of metastatic lesions (88% liver) were collected from a cohort of responders (N = 8) and non-responders (N = 8) based on RECIST v1.1 and examined by multiplex IHC and mRNA sequencing. Results: Treatment altered the transcriptional profile of metastatic lesions with a decrease in tumor cell proliferation independent of treatment response. The antiproliferative response was seen in both basal and classical PDA subtypes. PDA subtype was not associated with survival outcomes; instead, genes involved in immune activation distinguished responders from non-responders. Tumor response was associated with an increase in CD3+ and CD8+ T-cell infiltrates into metastatic lesions. A composite of decreased tumor proliferation in response to treatment and increased CD8 T-cell infiltration in metastatic lesions identified responders and associated with a favorable survival outcome. Conclusions: Our findings suggest that inhibiting cancer cell proliferation alone in PDA is insufficient to produce tumor responses and support a role for tumor-extrinsic mechanisms, such as CD8+ T cells, which combine with the cancer cell proliferation index to define treatment outcomes." @default.
- W4385514235 created "2023-08-04" @default.
- W4385514235 creator A5008330168 @default.
- W4385514235 creator A5010844431 @default.
- W4385514235 creator A5014753848 @default.
- W4385514235 creator A5018348657 @default.
- W4385514235 creator A5020724911 @default.
- W4385514235 creator A5029563022 @default.
- W4385514235 creator A5034393657 @default.
- W4385514235 creator A5044707124 @default.
- W4385514235 creator A5054626635 @default.
- W4385514235 creator A5066627784 @default.
- W4385514235 creator A5071938293 @default.
- W4385514235 creator A5075592761 @default.
- W4385514235 creator A5092587850 @default.
- W4385514235 date "2023-08-03" @default.
- W4385514235 modified "2023-10-18" @default.
- W4385514235 title "Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration" @default.
- W4385514235 cites W1497915798 @default.
- W4385514235 cites W1971420166 @default.
- W4385514235 cites W1975929837 @default.
- W4385514235 cites W2030612376 @default.
- W4385514235 cites W2100305481 @default.
- W4385514235 cites W2103017472 @default.
- W4385514235 cites W2115658806 @default.
- W4385514235 cites W2120426523 @default.
- W4385514235 cites W2151253787 @default.
- W4385514235 cites W2154790710 @default.
- W4385514235 cites W2157612047 @default.
- W4385514235 cites W2165480504 @default.
- W4385514235 cites W2169589032 @default.
- W4385514235 cites W2170202192 @default.
- W4385514235 cites W2273004055 @default.
- W4385514235 cites W2285093314 @default.
- W4385514235 cites W2470222015 @default.
- W4385514235 cites W2537335031 @default.
- W4385514235 cites W2592367290 @default.
- W4385514235 cites W2604808360 @default.
- W4385514235 cites W2618915943 @default.
- W4385514235 cites W2624910490 @default.
- W4385514235 cites W2734902361 @default.
- W4385514235 cites W2772548919 @default.
- W4385514235 cites W2885862304 @default.
- W4385514235 cites W2891572283 @default.
- W4385514235 cites W2901516234 @default.
- W4385514235 cites W2909786746 @default.
- W4385514235 cites W2919508314 @default.
- W4385514235 cites W2920097475 @default.
- W4385514235 cites W2920147611 @default.
- W4385514235 cites W2947826965 @default.
- W4385514235 cites W3011562658 @default.
- W4385514235 cites W3020766569 @default.
- W4385514235 cites W3042363085 @default.
- W4385514235 cites W3121346966 @default.
- W4385514235 cites W3136819448 @default.
- W4385514235 cites W3162325855 @default.
- W4385514235 cites W3167641883 @default.
- W4385514235 cites W3183310357 @default.
- W4385514235 cites W3203574804 @default.
- W4385514235 cites W4200519100 @default.
- W4385514235 cites W4206841660 @default.
- W4385514235 cites W4213175460 @default.
- W4385514235 cites W4296038861 @default.
- W4385514235 cites W4304084008 @default.
- W4385514235 cites W4310639010 @default.
- W4385514235 doi "https://doi.org/10.1158/1078-0432.ccr-23-0535" @default.
- W4385514235 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37534996" @default.
- W4385514235 hasPublicationYear "2023" @default.
- W4385514235 type Work @default.
- W4385514235 citedByCount "0" @default.
- W4385514235 crossrefType "journal-article" @default.
- W4385514235 hasAuthorship W4385514235A5008330168 @default.
- W4385514235 hasAuthorship W4385514235A5010844431 @default.
- W4385514235 hasAuthorship W4385514235A5014753848 @default.
- W4385514235 hasAuthorship W4385514235A5018348657 @default.
- W4385514235 hasAuthorship W4385514235A5020724911 @default.
- W4385514235 hasAuthorship W4385514235A5029563022 @default.
- W4385514235 hasAuthorship W4385514235A5034393657 @default.
- W4385514235 hasAuthorship W4385514235A5044707124 @default.
- W4385514235 hasAuthorship W4385514235A5054626635 @default.
- W4385514235 hasAuthorship W4385514235A5066627784 @default.
- W4385514235 hasAuthorship W4385514235A5071938293 @default.
- W4385514235 hasAuthorship W4385514235A5075592761 @default.
- W4385514235 hasAuthorship W4385514235A5092587850 @default.
- W4385514235 hasBestOaLocation W43855142352 @default.
- W4385514235 hasConcept C121608353 @default.
- W4385514235 hasConcept C126322002 @default.
- W4385514235 hasConcept C142724271 @default.
- W4385514235 hasConcept C143998085 @default.
- W4385514235 hasConcept C167672396 @default.
- W4385514235 hasConcept C203014093 @default.
- W4385514235 hasConcept C204232928 @default.
- W4385514235 hasConcept C2776694085 @default.
- W4385514235 hasConcept C2780210213 @default.
- W4385514235 hasConcept C2780258809 @default.
- W4385514235 hasConcept C71924100 @default.
- W4385514235 hasConcept C8891405 @default.
- W4385514235 hasConceptScore W4385514235C121608353 @default.